SCHEMBL31757733

SCHEMBL31757733

O=C(O)[C@@H](O)CN1CCOCC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
USP2 O75604 1/20 0.59
HSD17B10 Q99714 3/20 0.50
ANPEP P15144 1/20 0.47
GLA P06280 1/20 0.47
KDM4E B2RXH2 3/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
ATM Q13315 1/20 0.45
HIF1A Q16665 1/20 0.45
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
ABCB1 P08183 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29943240 0.84 OR51E2 (0.43) ALDH1A1USP2HSD17B10MAPTATM
SCHEMBL4150403 0.82 USP2 (0.57) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL4489543 0.82 USP2 (0.57) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL11604652 0.81 ALDH1A1 (0.63) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL838646 0.80 MEN1 (0.46) ALDH1A1HSD17B10ANPEPKDM4EMAPT
SCHEMBL27876610 0.80 USP2 (0.55) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL25662314 0.80 GLA (0.53) ALDH1A1USP2HSD17B10GLAKDM4E
SCHEMBL15049655 0.79 ALDH1A1 (0.61) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL5533637 0.79 ALDH1A1 (0.61) ALDH1A1USP2HSD17B10ANPEPGLA
SCHEMBL472331 0.78 MEN1 (0.56) ALDH1A1HSD17B10ANPEPMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF INSMED INCORPORATED 2026-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008758-A1 LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF DPP3, DPP7, DPP9 ALDH1A1 341/4885USP2 2150/4885HSD17B10 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.